Semaglutide: An Effective Solution for Type 2 Diabetes and Obesity Semaglutide, a groundbreaking medication, has proven highly effective in treating type 2 diabetes and obesity
Industry organizations such as the Alliance for Peptide Professionals are collaborating with regulators to establish safety, purity, and documentation standards for clinical-grade use
FDA cites potential immunogenicity from aggregation and peptide-related impurities and states that human safety data are limited
Persistent neurological symptoms, fatigue, or symptom recurrence before scheduled injections warrant medical review and possible dosage adjustment
The efficacy of a product depends on factors like concentration, stability, and skin penetration
Saxenda 6 mg/ml solution for injection in pre-filled pen Summary of Product Characteristics (Novo Nordisk)